107 related articles for article (PubMed ID: 1690252)
21. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
22. Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients.
Segal-Eiras A; Croce MV; Pasqualini CD
Arch Geschwulstforsch; 1983; 53(4):321-7. PubMed ID: 6312922
[TBL] [Abstract][Full Text] [Related]
23. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
Ohno M
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
[TBL] [Abstract][Full Text] [Related]
24. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
[TBL] [Abstract][Full Text] [Related]
25. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against surface antigens common to spermatogenic and F9 teratocarcinoma cells in mice immunized with blood group substances from human saliva.
Dráber P; Pokorná Z; Vojtísková M
Exp Clin Immunogenet; 1985; 2(3):174-82. PubMed ID: 3917147
[TBL] [Abstract][Full Text] [Related]
27. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
[TBL] [Abstract][Full Text] [Related]
29. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
Notter MF; Docherty JJ
Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
[TBL] [Abstract][Full Text] [Related]
30. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
[TBL] [Abstract][Full Text] [Related]
31. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
32. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
Kawana T; Cornish JD; Smith MF; Aurelian L
Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
[TBL] [Abstract][Full Text] [Related]
33. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
Takahashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
[TBL] [Abstract][Full Text] [Related]
34. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
36. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
37. Tumour-associated antigens in cervical cancer tissues and in the sera of Nigerian women with cervical cancer.
Adelusi B
Afr J Med Med Sci; 1982 Sep; 11(3):123-7. PubMed ID: 6307028
[TBL] [Abstract][Full Text] [Related]
38. Embryonic stem cells deficient in I beta1,6-N-acetylglucosaminyltransferase exhibit reduced expression of embryoglycan and the loss of a Lewis X antigen, 4C9.
Muramatsu H; Kusano T; Sato M; Oda Y; Kobori K; Muramatsu T
Glycobiology; 2008 Mar; 18(3):242-9. PubMed ID: 18184719
[TBL] [Abstract][Full Text] [Related]
39. Partial purification and characterization of tumor associated antigen in cervical carcinoma.
Das S; Chatterjee R; Chattopadhyay U; Roy Chowdhury J
Neoplasma; 1985; 32(1):21-30. PubMed ID: 2580245
[TBL] [Abstract][Full Text] [Related]
40. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
